Skip to main content

Find Clinical Trials

Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

NCT02356159

Conditions: Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

National Marrow Donor Program Minneapolis, Minnesota, United States

View Trial Details

Completed

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

NCT03731832

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik Munich, Bavaria, Germany

phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg Aschaffenburg, Germany

Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie Bamberg, Germany

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main Frankfurt am Main, Germany

View Trial Details

Completed

Financial Difficulty in Patients With Blood Cancer

NCT05212233

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations: University Of Alabama At Birmingham Birmingham, Alabama, United States

Mayo Clinic Cancer Center Phoenix, Arizona, United States

Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States

LSU Health Baton Rouge-North Clinic Baton Rouge, Louisiana, United States

View Trial Details

Completed

Description of the Impact of Symptoms on Quality of Life in HHT Disease: DISQUO

NCT07191639

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: Hôpital Femme-Mère-Enfant - Centre de référence pour la maladie de Rendu-Osler Bron, France

View Trial Details

Completed

PROFAST Intervention in Precursor Multiple Myeloma

NCT05565638

Conditions: Behavior, Blood Protein Disorders, Body Weight, +26 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70

NCT02858999

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CH Pays d'Aix Aix-en-Provence, France

CHU Amiens Amiens, France

CHU Besançon Besançon, France

CHU Caen Caen, France

View all 18 locations

View Trial Details

Completed

Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study

NCT06063603

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Leukemia, +17 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma

NCT01241708

Conditions: Auto Stem Cell Transplant, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: John Theurer Cancer Center @ Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank

NCT07152938

Conditions: Agnosia, Anxiety Disorders, Blood Protein Disorders, +39 more
Locations: Jenin governmental hospital Jenin, Palestinian Territories

AL-Watni governmental hospital Nablus, Palestinian Territories

Thabet Thabet governmental hospital Tulkarm, Palestinian Territories

View Trial Details

Completed

Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04045795

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: ~Banner MD Anderson Cancer Center Site Number : 8400005 Gilbert, Arizona, United States

City of Hope Site Number : 8400002 Duarte, California, United States

Gabrail Cancer Center Site Number : 8400001 Canton, Ohio, United States

Investigational Site Number : 0360002 Blacktown, New South Wales, Australia

View all 14 locations

View Trial Details